Company · Boucherville, Quebec, Canada
JAMP Pharma Corporation
Everything this company holds in Health Canada’s product databases, as the company’s name is spelled there.
- Drug products (DIN)
- 1,019
- 916 authorized now
- Natural health products
- 441
- 416 active licences
- Medical device licences
- 0
- 0 active
- Notices of Compliance
- 985
Drug products
Authorized products first.
Showing 300 of 1,019 drug products. For the rest, search Health Canada’s database.
Natural health products
Active licences first, newest first.
Showing 300 of 441 licences. For the rest, search Health Canada’s database.
Notices of Compliance
Newest first.
- JAMP ELTROMBOPAGOctober 9, 2026 · NOC 38440 · Abbreviated New Drug Submission (ANDS)
- JAMP IBUPROFENOctober 9, 2026 · NOC 38451 · Abbreviated New Drug Submission (ANDS)
- JAMP ELAGOLIXOctober 6, 2026 · NOC 38410 · Abbreviated New Drug Submission (ANDS)
- JAMP-MYCOPHENOLATE CAPSULESOctober 1, 2026 · NOC 38391 · Supplement to an Abbreviated New Drug Submission (SANDS)
- JAMP LISDEXAMFETAMINESeptember 18, 2026 · NOC 38314 · Supplement to an Abbreviated New Drug Submission (SANDS)
- JAMP CALCITRIOLSeptember 18, 2026 · NOC 38320 · Abbreviated New Drug Submission (ANDS)
- JAMP VALPROIC ACID ORAL SOLUTIONSeptember 18, 2026 · NOC 38323 · Supplement to an Abbreviated New Drug Submission (SANDS)
- JAMP ARIPIPRAZOLE ORAL SOLUTIONSeptember 16, 2026 · NOC 38291 · Supplement to a New Drug Submission (SNDS)
- JAMP-CITALOPRAMSeptember 16, 2026 · NOC 38292 · Supplement to an Abbreviated New Drug Submission (SANDS)
- JAMP-DULOXETINESeptember 16, 2026 · NOC 38297 · Supplement to an Abbreviated New Drug Submission (SANDS)
- JAMP ACYCLOVIRSeptember 9, 2026 · NOC 38254 · Abbreviated New Drug Submission (ANDS)
- JAMP LEVETIRACETAM SOLUTIONSeptember 8, 2026 · NOC 38253 · Abbreviated New Drug Submission (ANDS)
- JAMP DIVALPROEXSeptember 4, 2026 · NOC 38260 · Supplement to an Abbreviated New Drug Submission (SANDS)
- JAMP TOBRAMYCIN / DEXAMETHASONESeptember 1, 2026 · NOC 38207 · Abbreviated New Drug Submission (ANDS)
- JAMP RAMIPRILSeptember 1, 2026 · NOC 38210 · Supplement to an Abbreviated New Drug Submission (SANDS)
- JAMP METRONIDAZOLE GELAugust 28, 2026 · NOC 38193 · Abbreviated New Drug Submission (ANDS)
- JAMP TOLTERODINEAugust 27, 2026 · NOC 38180 · Supplement to an Abbreviated New Drug Submission (SANDS)
- JAMP DOXEPIN TABLETSAugust 26, 2026 · NOC 38170 · Abbreviated New Drug Submission (ANDS)
- JAMP DOXEPIN TABLETSAugust 26, 2026 · NOC 38174 · Supplement to an Abbreviated New Drug Submission (SANDS)
- JAMP FOSFOMYCINAugust 26, 2026 · NOC 38177 · Supplement to an Abbreviated New Drug Submission (SANDS)
- JAMP TOFACITINIBAugust 21, 2026 · NOC 38158 · Supplement to an Abbreviated New Drug Submission (SANDS)
- JAMP NINTEDANIBAugust 19, 2026 · NOC 38140 · Supplement to an Abbreviated New Drug Submission (SANDS)
- JAMP MIRTAZAPINEAugust 12, 2026 · NOC 38109 · Abbreviated New Drug Submission (ANDS)
- JAMP TOFACITINIBAugust 11, 2026 · NOC 38088 · Supplement to an Abbreviated New Drug Submission (SANDS)
- JAMP-ZOLEDRONIC ACIDAugust 7, 2026 · NOC 38077 · Supplement to an Abbreviated New Drug Submission (SANDS)
- GLYCOPYRROLATE INJECTION USP (PRESERVATIVE FREE); GLYCOPYRROLATE INJECTION USP (WITH PRESERVATIVE)July 30, 2026 · NOC 38022 · Supplement to an Abbreviated New Drug Submission (SANDS)
- JAMP-ZOPICLONE TABLETSJuly 28, 2026 · NOC 37994 · Supplement to an Abbreviated New Drug Submission (SANDS)
- JAMP RAMIPRIL CAPSULESJuly 24, 2026 · NOC 37980 · Abbreviated New Drug Submission (ANDS)
- JAMP VORICONAZOLEJuly 24, 2026 · NOC 37984 · Supplement to an Abbreviated New Drug Submission (SANDS)
- JAMP VALACYCLOVIRJuly 13, 2026 · NOC 37906 · Supplement to an Abbreviated New Drug Submission (SANDS)
- JAMP-AMOXICILLINJuly 13, 2026 · NOC 37911 · Supplement to an Abbreviated New Drug Submission (SANDS)
- JAMP RISPERIDONEJuly 10, 2026 · NOC 37873 · Supplement to an Abbreviated New Drug Submission (SANDS)
- XDENOJuly 10, 2026 · NOC 37879 · New Drug Submission (NDS)
- ODENSIFYJuly 10, 2026 · NOC 37880 · New Drug Submission (NDS)
- JAMP ROSUVASTATIN TABLETSJuly 10, 2026 · NOC 37886 · Supplement to an Abbreviated New Drug Submission (SANDS)
- JAMP AMBRISENTANJuly 9, 2026 · NOC 37861 · Supplement to an Abbreviated New Drug Submission (SANDS)
- JAMP RABEPRAZOLEJune 24, 2026 · NOC 37761 · Supplement to an Abbreviated New Drug Submission (SANDS)
- JAMP DILTIAZEM CDJune 19, 2026 · NOC 37744 · Supplement to an Abbreviated New Drug Submission (SANDS)
- JAMP TACROLIMUS OINTMENTJune 18, 2026 · NOC 37734 · Abbreviated New Drug Submission (ANDS)
- JAMP DULOXETINEJune 18, 2026 · NOC 37737 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PEXEGRAJune 12, 2026 · NOC 37699 · Supplement to a New Drug Submission (SNDS)
- JAMP NAPROXENJune 2, 2026 · NOC 37639 · Abbreviated New Drug Submission (ANDS)
- VORICONAZOLE FOR INJECTIONMay 26, 2026 · NOC 37619 · Supplement to an Abbreviated New Drug Submission (SANDS)
- JAMP GUANFACINE XRMay 25, 2026 · NOC 37603 · Supplement to an Abbreviated New Drug Submission (SANDS)
- JAMP BICALUTAMIDEMay 21, 2026 · NOC 37586 · Supplement to an Abbreviated New Drug Submission (SANDS)
- IBUPROFEN LIQUID GELMay 15, 2026 · NOC 37550 · Supplement to an Abbreviated New Drug Submission (SANDS)
- JAMP LENALIDOMIDEMay 15, 2026 · NOC 37561 · Supplement to an Abbreviated New Drug Submission (SANDS)
- JAMP IPRATROPIUM HFAMay 15, 2026 · NOC 37562 · Supplement to an Abbreviated New Drug Submission (SANDS)
- JAMP TICAGRELORMay 14, 2026 · NOC 37546 · Supplement to an Abbreviated New Drug Submission (SANDS)
- JAMP METHOTREXATE TABLETSMay 11, 2026 · NOC 37514 · Supplement to an Abbreviated New Drug Submission (SANDS)
- JAMP NINTEDANIBMay 11, 2026 · NOC 37521 · Supplement to an Abbreviated New Drug Submission (SANDS)
- FILRAMay 7, 2026 · NOC 37506 · Supplement to a New Drug Submission (SNDS)
- JAMP DICLOFENAC FOR SOLUTIONMay 6, 2026 · NOC 37480 · Supplement to an Abbreviated New Drug Submission (SANDS)
- JAMP MIFEPRISTONE / MISOPROSTOLMay 6, 2026 · NOC 37487 · Abbreviated New Drug Submission (ANDS)
- JAMP DICLOFENAC FOR SOLUTIONMay 6, 2026 · NOC 37488 · Abbreviated New Drug Submission (ANDS)
- JAMP-DULOXETINEMay 5, 2026 · NOC 37478 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PEXEGRAMay 1, 2026 · NOC 37452 · Supplement to a New Drug Submission (SNDS)
- JAMP RIVAROXABANMay 1, 2026 · NOC 37464 · Supplement to an Abbreviated New Drug Submission (SANDS)
- CAPECITABINEMay 1, 2026 · NOC 37465 · Supplement to an Abbreviated New Drug Submission (SANDS)
- JAMP APIXABANMay 1, 2026 · NOC 37467 · Supplement to an Abbreviated New Drug Submission (SANDS)
- JAMP CANDESARTAN-HCTApril 24, 2026 · NOC 37399 · Supplement to an Abbreviated New Drug Submission (SANDS)
- CITALOPRAMApril 23, 2026 · NOC 37391 · Supplement to an Abbreviated New Drug Submission (SANDS)
- JAMP INDAPAMIDEApril 23, 2026 · NOC 37392 · Abbreviated New Drug Submission (ANDS)
- JAMP SUMATRIPTAN DFApril 17, 2026 · NOC 37347 · Supplement to an Abbreviated New Drug Submission (SANDS)
- JAMP LISDEXAMFETAMINEApril 17, 2026 · NOC 37348 · Supplement to an Abbreviated New Drug Submission (SANDS)
- JAMP SPIRONOLACTONEApril 15, 2026 · NOC 37326 · Supplement to an Abbreviated New Drug Submission (SANDS)
- JAMP DIVALPROEXApril 15, 2026 · NOC 37327 · Supplement to an Abbreviated New Drug Submission (SANDS)
- UPGOLYVApril 10, 2026 · NOC 37311 · New Drug Submission (NDS)
- JAMP-OMEPRAZOLE DRApril 9, 2026 · NOC 37294 · Supplement to an Abbreviated New Drug Submission (SANDS)
- METFORMIN XRApril 8, 2026 · NOC 37282 · Abbreviated New Drug Submission (ANDS)
- JAMP BIMATOPROSTApril 8, 2026 · NOC 37293 · Abbreviated New Drug Submission (ANDS)
- JAMP MINOXIDIL SOLUTIONApril 2, 2026 · NOC 37276 · Supplement to an Abbreviated New Drug Submission (SANDS)
- CITALOPRAMApril 1, 2026 · NOC 37232 · Supplement to an Abbreviated New Drug Submission (SANDS)
- JAMP ZOPICLONEApril 1, 2026 · NOC 37233 · Supplement to an Abbreviated New Drug Submission (SANDS)
- JAMP GABAPENTIN TABLETSMarch 30, 2026 · NOC 37223 · Supplement to an Abbreviated New Drug Submission (SANDS)
- JAMP VALPROIC ACID ORAL SOLUTIONMarch 27, 2026 · NOC 37203 · Supplement to an Abbreviated New Drug Submission (SANDS)
- JAMP TOFACITINIBMarch 27, 2026 · NOC 37221 · Supplement to an Abbreviated New Drug Submission (SANDS)
- JAMP HYDROXYCHLOROQUINE SULFATEMarch 26, 2026 · NOC 37196 · Supplement to an Abbreviated New Drug Submission (SANDS)
- JAMP SUMATRIPTAN / NAPROXEN SODIUMMarch 25, 2026 · NOC 37184 · Abbreviated New Drug Submission (ANDS)
- JAMP COLESEVELAMMarch 20, 2026 · NOC 37147 · Abbreviated New Drug Submission (ANDS)
- JAMP ENZALUTAMIDEMarch 18, 2026 · NOC 37126 · Supplement to an Abbreviated New Drug Submission (SANDS)
- JAMP BIMATOPROST SOLUTION RCMarch 16, 2026 · NOC 37108 · Abbreviated New Drug Submission (ANDS)
- JAMP-GABAPENTINMarch 12, 2026 · NOC 37089 · Supplement to an Abbreviated New Drug Submission (SANDS)
- JAMP CELECOXIBMarch 12, 2026 · NOC 37100 · Supplement to an Abbreviated New Drug Submission (SANDS)
- JAMP PRAVASTATIN TABLETSMarch 11, 2026 · NOC 37079 · Supplement to an Abbreviated New Drug Submission (SANDS)
- JAMP IRBESARTANMarch 6, 2026 · NOC 37054 · Supplement to an Abbreviated New Drug Submission (SANDS)
- JAMP TOPIRAMATE TABLETSFebruary 27, 2026 · NOC 37007 · Supplement to an Abbreviated New Drug Submission (SANDS)
- JAMP POMALIDOMIDEFebruary 27, 2026 · NOC 37009 · Supplement to an Abbreviated New Drug Submission (SANDS)
- JAMP TEMAZEPAMFebruary 16, 2026 · NOC 36908 · Abbreviated New Drug Submission (ANDS)
- JAMP ENZALUTAMIDEFebruary 10, 2026 · NOC 36869 · Supplement to an Abbreviated New Drug Submission (SANDS)
- JAMP ACITRETINFebruary 6, 2026 · NOC 36844 · Supplement to an Abbreviated New Drug Submission (SANDS)
- JAMP DILTIAZEM TFebruary 5, 2026 · NOC 36849 · Supplement to an Abbreviated New Drug Submission (SANDS)
- JAMP ENZALUTAMIDEFebruary 4, 2026 · NOC 36829 · Abbreviated New Drug Submission (ANDS)
- JAMP ENZALUTAMIDEFebruary 4, 2026 · NOC 36833 · Supplement to an Abbreviated New Drug Submission (SANDS)
- JAMP-CETIRIZINEJanuary 21, 2026 · NOC 36753 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AMIODARONE HYDROCHLORIDE FOR INJECTIONJanuary 21, 2026 · NOC 36759 · Supplement to an Abbreviated New Drug Submission (SANDS)
- JAMP BRIMONIDINEJanuary 21, 2026 · NOC 36760 · Supplement to an Abbreviated New Drug Submission (SANDS)
- JAMP FENOFIBRATE EJanuary 16, 2026 · NOC 36745 · Abbreviated New Drug Submission (ANDS)
- JAMP CLONIDINE TABLETSJanuary 9, 2026 · NOC 36703 · Abbreviated New Drug Submission (ANDS)
- JAMP CANAGLIFLOZINJanuary 2, 2026 · NOC 36658 · Abbreviated New Drug Submission (ANDS)
The latest 100 of 985.
Recalls and safety alerts that mention its products
Health Canada’s recall notices do not carry licence numbers, so these are matched by name. A notice may cover another product or only some lots: read it to see what it covers.
- JAMP-ASA 81 mg EC; Out of specification (salicylic acid impurity)January 5, 2026 · Drugs · Product quality · Type II
- JAMP-Risperidone 0.25mg: Out of specification (Stability)November 19, 2025 · Drugs · Product quality · Type III
- Jamp-Hydralazine tablet: Affected lot may contain Jamp-Hydralazine 10 mg tabletsJune 10, 2025 · Drugs · Product safety · Type II
- JAMP-RISPERIDONE: may contain foreign matter particlesMay 30, 2025 · Drugs · Product safety · Type III
- JAMP-ASA 81MG EC: may contain foreign tablets containing acetaminophen and methocarbamolMay 28, 2025 · Drugs · Product safety · Type II
- JAMP-Pregabalin: One lot recalled as some bottles may contain 150 mg capsulesMay 5, 2025 · Drugs · Product safety · Type I
- JAMP-Pregabalin 50 mg: One lot recalled as some bottles may contain 150 mg capsulesMay 3, 2025 · Drugs · Product safety
- JAMP-MONTELUKAST 10mg: may contain foreign fragments of pink candesartan tabletsApril 24, 2025 · Drugs · Contamination · Type II
- JAMP-FeR: Yeasts and molds count is out of specificationNovember 14, 2024 · Natural health products · Product quality · Type II
- Pregnancy Multivitamin, Pregnancy Multivitamin Folic 5: Affected lots exceed the acceptable intake limit for N-nitroso-folic acidNovember 6, 2024 · Drugs · Product safety · Type II
- Jamp-Finasteride tablet; Out-of-specification (Finasteride content)October 15, 2024 · Drugs · Product quality · Type II
- JAMP-Clopidogrel : may contain overweight or underweight tabletsSeptember 6, 2024 · Drugs · Product quality · Type I
- All lots of JAMP-Clopidogrel 75 mg and AG-Clopidogrel 75 mg tablets recalled due to possible incorrect dose, which may pose health risksSeptember 5, 2024 · Drugs · Product safety - Dosage
- JAMP-ASA EC: Out of SpecificationAugust 20, 2024 · Drugs · Product safety · Type II
- JAMP-Mycophenolate 250 mg capsules: Affected lots may contain overweight or underweight capsulesAugust 19, 2024 · Drugs · Product safety · Type I
- All lots of JAMP-Mycophenolate 250 mg capsules recalled due to possible incorrect dose, which may pose health risksAugust 16, 2024 · Drugs · Product safety
- JAMP-Doxazosin 4 mg: The uniformity of dosage unit may be out of specification in the affected lot.June 25, 2024 · Drugs · Product quality · Type II
- Audrina 28 birth control pills: Day-of-the-week stickers in some lots have a misprint that could lead to confusion around dosingFebruary 20, 2024 · Drugs · Labelling
- JAMP-ASA EC: out of specificationDecember 4, 2023 · Drugs · Product quality · Type II
- JAMP-URSODIOL: Dissolution is out of specification in affected lotsJuly 28, 2023 · Drugs · Product quality · Type II
- JAMP-ASA EC: Product QualityApril 20, 2023 · Drugs · Product quality · Type II
- SIMLANDI: Product QualityApril 17, 2023 · Drugs · Product quality · Type II
- Jamp-Calcium + Vitamin D 1000 IU: Presence of foreign matter in affected lot.February 13, 2023 · Natural health products · Product quality · Type II
- Recall of one lot of Jamp-Atorvastatin Calcium as some bottles may be labelled as containing 10 mg tablets, but contain 40 mg tabletsAugust 27, 2022 · Drugs · Dosage - Labelling
- Jamp-Vitamin D: Out of SpecificationAugust 22, 2022 · Drugs · Product quality · Type II
- JAMP-ATORVASTATIN: The affected lot may contain latex.August 8, 2022 · Drugs · Contamination · Type I
- Jamp-Atorvastatin 40 mg tablets recalled due to risk of latex contaminationAugust 6, 2022 · Drugs · Contamination
- JAMP-Cetirizine: ImpurityNovember 9, 2021 · Drugs · Product quality · Type II
- Jamp-Metformin Product Recall (2020-03-10)March 10, 2020 · Drugs · Product safety · Type I
- Jamp-Glucose 50 and Jamp-Glucose 75 – Risk of False Negative Oral Glucose Challenge or Tolerance Test ResultsJune 7, 2018 · Natural health products · Product safety
- Jamp-Ibuprofen (2017-07-17)October 4, 2017 · Drugs · Product safety · Type III
- Jamp-Metoprolol-L (2017-07-17)October 4, 2017 · Drugs · Product safety · Type III
- Jamp-Hydrocortisone Cream 1% (2016-03-17)April 8, 2016 · Natural health products · Product safety · Type II
- Information Update - Jamp-Hydrocortisone Cream 1% recalled due to contamination with bacteria, yeast and mouldMarch 24, 2016 · Natural health products
- Jamp-Methotrexate (2015-03-13)March 17, 2015 · Drugs · Product safety · Type I
- Jamp-Methotrexate Injection USP 50mg/2 mL - Voluntary Recall Due to the Potential Presence of Foreign Particulate MatterMarch 14, 2015 · Drugs · Product safety
- Jamp Pharma Corp Recalls Jamp-Methotrexate (USP 50mg/2mL) Due To Particulate MatterMarch 13, 2015 · Drugs
- Jamp-Quinine (2014-11-21)December 12, 2014 · Natural health products · Product safety · Type II
- Jack and Jill ExpectorantFebruary 28, 2013 · Drugs · Product safety · Type I